We discovered that patients with CHD had increased expression of the m6A regulators NXF1, ALKBH, HNRNPC, FMR1, HNRNPA2B1, WTAP, YTHDC1, and YTHDF3, whereas individuals without CHD had lower expression of the other important m6A regulators (Figures 3A,B). The gene discussed is METTL3; the disease is coronary artery disorder.